Last reviewed · How we verify
NCT04889001: Sim-II
Ventilation Knowledge and Skills Retention Using a Novel Tool, the Augmented Infant Resuscitator (AIR) Device as an Instant-feedback Tool
NA trial testing Simulation enhanced HBB training in Ventilation Skills Acquisition and Retention in 400 participants. Status unknown.
30 December 2022
Quick facts
| Lead sponsor | Mbarara University of Science and Technology |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 400 |
| Start date | 1 October 2021 |
| Primary completion | 30 December 2022 |
| Estimated completion | 30 December 2023 |
Drugs / interventions tested
- Simulation enhanced HBB training
Conditions studied
- Ventilation Skills Acquisition and Retention — all drugs for Ventilation Skills Acquisition and Retention →
- Ventilation Knowledge Acquisition and Retention — all drugs for Ventilation Knowledge Acquisition and Retention →
Sponsor
Mbarara University of Science and Technology
Who can join
18 and older, any sex, with Ventilation Skills Acquisition and Retention or Ventilation Knowledge Acquisition and Retention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Babies born not breathing at birth require effective gentle ventilation to survive and avert organ damage if initial resuscitation steps such as drying, and stimulation are unsuccessful at facilitating breathing. Training of health workers to impart skills on ventilation is a way to prevent these adverse outcomes. Effective ventilation skills are typically acquired through training programs such as Helping Babies Breath (HBB). However, these ventilation skills quickly decay following training and current skills retention methods such as refresher courses are costly and there is a paucity of skilled human resources to effectively facilitate frequent HBB training courses. This raises the need to explore approaches that are independent of retraining for skills maintenance. The investigators hypothesize that simulation enhanced HBB training followed by self-administered ventilation practice (SAVP) sessions with the Augmented Infant Resuscitator (AIR) as an electronic coach will result into ventilation skills retention over 12 months. SAVP allows participants to maintain practice and training to enhance skills retention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04889001
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Mbarara University of Science and Technology trials
Trials by the same sponsor.
- NCT07067528 — The Feasibility and Acceptability of a Post-tuberculosis Lung Disease Diagnostic Algorithm in Uganda. · NA · not yet recruiting
- NCT06545968 — A Social Media Intervention to Improve Retention in Care for Adolescents and Young Adults With HIV in Uganda · NA · recruiting
- NCT05940831 — Mobile Health Intervention (Support-moms) in Antenatal Care to Improve Maternal Health in Uganda · NA · recruiting
- NCT05073705 — Self-management of HIV Among Adolescents · NA · completed
- NCT05979194 — WHO Labor Care Guide for Obstetric Care Providers in Public Health Facilities in Mbarara, Southwestern Uganda · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04889001 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mbarara University of Science and Technology
- Last refreshed: 17 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04889001.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing